Close Menu
NEW YORK (GenomeWeb News) - The US Food and Drug Administration has approved Abbott Laboratories' HIV-1 viral load prognostic test for use on its m2000 RT-PCR platform, Abbott and development partner Celera said on Friday.
 
The companies said the RealTime HIV-1 assay measures the levels of HIV circulating in a patient's bloodstream, including the three common HIV-1 groups and non-B subtypes. Abbott said the test is used for disease prognosis and to assess response to antiretroviral treatment.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.